0001209191-22-033206.txt : 20220601
0001209191-22-033206.hdr.sgml : 20220601
20220601170233
ACCESSION NUMBER: 0001209191-22-033206
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220519
FILED AS OF DATE: 20220601
DATE AS OF CHANGE: 20220601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dunn Judith
CENTRAL INDEX KEY: 0001811904
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40708
FILM NUMBER: 22988167
MAIL ADDRESS:
STREET 1: C/O SEELOS THERAPEUTICS, INC.
STREET 2: 300 PARK AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eliem Therapeutics, Inc.
CENTRAL INDEX KEY: 0001768446
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832273741
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 23515 NE NOVELTY HILL ROAD
STREET 2: SUITE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
BUSINESS PHONE: 425-276-2300
MAIL ADDRESS:
STREET 1: 23515 NE NOVELTY HILL ROAD
STREET 2: SUITE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-19
0
0001768446
Eliem Therapeutics, Inc.
ELYM
0001811904
Dunn Judith
C/O ELIEM THERAPEUTICS, INC.
23515 NE NOVELTY HILL RD, STE. B221 #125
REDMOND
WA
98053
1
0
0
0
Stock Option (Right To Buy)
3.46
2022-05-19
4
A
0
10000
0.00
A
2032-05-18
Common Stock
10000
10000
D
The shares subject to the option will vest on the earlier of May 19, 2023 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.
/s/ Brian Woodard, Attorney-in-Fact
2022-06-01